Medicine
Palsonify 20 mg tablet
Palsonify 20 mg tablet is a prescription medicine containing Paltusotine for oral use, marketed by Crinetics Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store tablets at 20°C to 25°C (68°F to 77°F). Excursions permitted 15°C to…
Key facts
- Active ingredient (INN)
- Paltusotine
- Brand
- Palsonify
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 60 tablets
- Marketing authorisation holder
- Crinetics Pharmaceuticals
- Manufacturer
- Crinetics Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store tablets at 20°C to 25°C (68°F to 77°F). Excursions permitted 15°C to 30°C (59°F to 86°F). Store and dispense in original container or USP equivalent tight container.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- H01CB06 Paltusotine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 September 2025
- Identifiers
- RxCUI 2724403, 2724409, 2724411 +1DailyMed set ID 8a6d2ce0-a621-4ee7-983c-977cd948ff4dNDC 84015-920Application NDA219070
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 60 tablet, film coated in 1 bottle | 84015-920-60 | Crinetics Pharmaceuticals | 25 September 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Paltusotine
Clinical summary
Paltusotine is a prescription medicine indicated for the treatment of adults with acromegaly who had an inadequate response to surgery and/or for whom surgery is not an option. It is available as tablets for oral use. MedsAcross supplies Paltusotine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PaltusotineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PALSONIFY prescribing information (Crinetics Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Palsonify: European public assessment report (EPAR) · European Medicines Agency
Need Palsonify 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.